Connect with us

News

Lanka lucky to get substantial supplies of Sinopharm, but we are paying for following failed playbook of US, UK – Dr. Rannan-Eliya

Published

on

Given that Sri Lanka has access to substantial supplies of Sinopharm vaccine, Sinovac is not a good choice any longer, since Sinopharm is much better in terms of immune protection, Executive Director of the Institute for Health Policy (IHP), Dr. Ravi Rannan-Eliya says.

Dr. Eliya said that if Sri Lanka had actually stuck to President Gotabaya Rajapaksa’s official strategy of preventing and stopping outbreaks, then Sinovac might have had a role, since even a partially effective vaccine can help in reducing the cost of maintaining a COVID- free country. He added that “this essentially what China is doing right now”.

“China doesn’t need the best vaccines, just vaccines good enough to slow transmission enough to allow other control measures to beat the virus, without putting the whole country in lockdown. But we are not China. We have followed the failed playbook that the UK and the USA adopted. So we have widespread transmission in the community and literally thousands of deaths each month. So for us, buying and deploying Sinopharm, topped up with Moderna, Pfizer and Sputnik seems to be best strategy for now, with the exact mix depending on what is available quickly in quantity. Moreover, given that thousands are dying and will continue to die until the virus slows down by infecting enough people, speed and quantity are the biggest considerations, and no longer cost, since we have already made the decision to go for broke…and I mean that literally!,” he said.

Given below are excerpts of his statement: “I was asked the other day for my thoughts on the local approval and use of Sinovac, so just sharing my general take on this. Sinovac was given an emergency use license (EUL) by our NMRA on 16 July 2021, six weeks after WHO had given its EUL (1 Jun 2021). We have since not purchased it as far as I know and certainly not used it, so why?

“SHOULD SINOVAC BE APPROVED FOR EMERGENCY USE DURING THIS ONGOING COVID PANDEMIC?

“The answer to that is fairly simply – YES. This basically boils down to two considerations: (1) Does it work? (2) Is it safe enough for emergency use, given the limited evidence that any vaccine will have in an emergency scenario? This is the decision that WHO came to (and they are really slow when it comes to non-US/UK/EU vaccines), and the same decision that robust regulatory authorities in places like Hong Kong, Chile came to months before WHO. Given that and given the reality that we faced of tight global supplies of COVID vaccines, our local NMRA approval was in fact if anything rather slow. The second question is whether we should use or purchase it.

“SHOULD SINOVAC BE USED IN OUR SRI LANKAN COVID VACCINATION STRATEGY?

“The question of whether Sinovac should be used in our national COVID vaccination strategy is a completely separate one, and not one that NMRA should or could decide. This separate decision needs to be based on the overall public health strategy, plus COST and AVAILABILITY considerations. The bottom line here is that the answer depends on what our alternatives are, and how desperate we are to boost population immunity.

“There are three things to know about Sinovac. First, it is not as effective in stopping severe illness and also in stopping transmission as Sinopharm or Astra-Zeneca, and much less effective than the mRNA vaccines, like Pfizer and Moderna. Second, it is much more available to developing countries than Astra-Zeneca, Pfizer and Moderna, because Sinovac is being produced in the billions of doses and most Western countries aren’t buying it. Third, although Sinopharm is a better vaccine, Sinovac was available in bulk outside China much earlier, because Sinovac, a commercial firm, was much faster in getting approvals than the more lethargic, state-run Sinopharm.

“So Sinovac has been put to use in many countries, including in Europe and also some OECD countries, such as Chile and Mexico. GAVI has also signed agreements to purchase Sinovac for global distribution through the COVAX programme. For practical reasons. Sinovac and also Sinopharm are the only vaccines that are available in sufficient bulk to allow COVAX to deliver on its commitments to developing countries, so COVAX desperately needs both Sinovac and Sinopharm. So there is a rational case for purchasing Sinovac in bulk in many countries, and even Western-dominated entities like GAVI have come to this conclusion.

“However, for us in Sri Lanka, where we appear to now have substantial supplies of mostly Sinopharm vaccines, Sinovac is not a good choice any longer, since Sinopharm is much better in terms of immune protection. This means that with continuing widespread transmission (since contrary to President’s Official COVID Strategy, our real strategy has been for months to live and die! with the virus), Sinovac will require boosters earlier, and it will thus end up being more costly.”



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Most bribery cases fall through owing to CIABOC’s lapses

Published

on

Viyangoda points out President silent on AG

By Shamindra Ferdinando

The majority of cases filed by the CIABOC (Commission to Investigate Allegations of Bribery or Corruption) had been withdrawn primarily on technical grounds, mainly the absence of sanction of all three commissioners, those familiar with the process told The Island.

In terms of the previous bribery Act, the sanction of all commissioners was a must, sources said. The Act made written sanction of three commissioners compulsory before an indictment was drafted, sources said, adding that remedial measures were taken through the new bribery act.

The then Justice Minister Dr. Wijeyadasa Rajapakse, PC, introduced Anti-Corruption Act No 09 of 2023.

Sources said so responding to harsh criticism of the CIABOC by President Anura Kumara Dissanayake at the ‘International Anti-Corruption Day National Celebration at the Bandaranaike Memorial International Conference Hall (BMICH).

President’s Media Division (PMD) quoted National People’s Power (NPP) leader who is also the chief of Janatha Vimukthi Peremuna (JVP) as having disclosed that of 69 cases that had been filed in 2021, 40 were later withdrawn. Similarly, in the following year of 89 cases that had been filed, 45 were later withdrawn, the President was quoted as having said at the Dec 09 event.

Declaring that the public had a right to know the circumstances under which so many cases were withdrawn within two years, President Dissanayake called for an explanation from CIABOC as to why investigating officers failed to appear as witnesses in these cases.

President rapped the CIABOC in the presence of its new leadership. The then President Ranil Wickremesinghe appointed W.M.N.P. Iddawala, former Judge of the Court of Appeal and Deputy Secretary General of Parliament as the new Chairman. Its other members are Bernard Rajapakse, former Senior Deputy General Manager of People’s Bank, and Chethiya Goonesekera, President’s Counsel and Additional Solicitor General of the Attorney General’s Department. They assumed duties on January 01, 2024.

Responding to The Island queries, sources emphasised that the responsibility for creating a situation that led to the withdrawal of so many cases-a staggering 85 cases out of 158 within two years lies with the respective commissions. Sources explained that the indictments that had been filed and later withdrawn in 2021 and 2022 weren’t moved by the commissions in place during that period.

Sources also questioned the role of the Director General of the CIABOC in the crisis created within the set up.

Commissioners are appointed on the recommendation of the Constitutional Council headed by the Speaker of Parliament.

As a result of political compulsions some commissioners had been in an indecent hurry to indict targeted persons hastily, sources said. There had been cases where indictments had been filed before the completion of inquiries, sources added, pointing out that when the defendants’ side took up objection in court, CIABOC had no option but to withdraw cases.

The new government couldn’t be unaware that the CIABOC had refiled some of the indictments. But, unfortunately in some cases there was no evidence to file an indictment, sources said.

Due to covid-19 eruption, the CIABOC suffered and during 20/21 period there hadn’t been any fresh indictments, sources said, adding that those filed during the yahapalana administration (2015-2019) were pursued.

Sources said that the powers that be needed to seriously examine the gradual weakening of the system overwhelmed by the political party system.

Civil society activist Gamini Viyangoda who on behalf of Purawesi Balaya raised the withdrawal of high profile cases that had been filed during yahapalana administration yesterday (25) told The Island that culpability of the CIABOC couldn’t be discussed without examining the conduct of the Attorney General’s Department.

The President, in his criticism of the failure on the part of CIABOC hadn’t referred to the AG’s Department at all, Viyangoda pointed out.

Viyangoda alleged Sri Lanka never had an apparatus that honestly pursued cases of waste, corruption and irregularities. Those assigned the task instead of fulfilling their objectives sought to appease their political masters and other interested parties at the expense of good governance and accountability.

Viyangoda emphasised that both CIABOC and AG’s Department had been neglected, resulting in extremely careless and serious shortcomings on the part of the two vital bodies. But, the primary issue is nothing but political interference and those in key positions of the above mentioned bending backwards to facilitate political agendas, he alleged.

Viyangoda asserted that a change couldn’t be expected as long as the government took tangible measures to end political interference in the judiciary, police, CIABOC and AG’s Department.

A major drawback is that successive governments had failed to adhere to the laws of the land, Viyangoda said, urging the parliament to address the issues at hand pertaining to corruption without further delay.

Continue Reading

News

Prime Minister visits Chinese Hospital Ship “Peace Ark” at Colombo Port

Published

on

Prime Minister Dr. Harini Amarasuriya visited the Chinese Navy hospital ship "Peace Ark" at the Port of Colombo on Tuesday morning (24). Chinese Ambassador to Sri Lanka Qi Zhenhong and the Secretary to the Prime Minister, Pradeep Saputhanthri too were present.

Prime Minister Dr. Harini Amarasuriya visited the Chinese Navy hospital ship “Peace Ark” at the Port of Colombo Tuesday morning (24). Chinese Ambassador to Sri Lanka Qi Zhenhong and the Secretary to the Prime Minister, Pradeep Saputhanthri too were present.

The Peace Ark arrived at the Port of Colombo on 21 December and will provide free medical examinations and treatment services to the people of Sri Lanka from 22 December to 27 December.

During her visit, the Prime Minister commended the humanitarian efforts of the Peace Ark and expressed appreciation to the Chinese government for extending this gesture of goodwill to the Sri Lankan people. She highlighted the importance of such initiatives in maintaining bilateral relations and supporting public health.

The Chinese Ambassador emphasized the importance of the ship’s mission in strengthening cooperation between Sri Lanka and China, while the ship’s medical team showcased the state-of-the-art facilities and services available onboard.

Continue Reading

News

Salt production can help create jobs for youth in North and East, says expert

Published

on

A worker at Hambantota saltern. (Picture courtesy Lanka Salt Ltd.)

By Rathindra Kuruwita

Sri Lanka’s Northern and Eastern provinces are ideal locations for establishing salterns, which could support ancillary domestic industries creating a range of new employment opportunities for the youth in those parts of the counntry, says Dr Mahinsasa Rathnayake, Senior Lecturer at the Department of Chemical and Process Engineering, Faculty of Engineering, University of Moratuwa

In an interview with Asoka Dias on Sirasa, Dr. Rathnayake, commenting on the government’s recent decision to import salt, said such imports consisted mainly of raw, non-iodised salt intended for industrial applications. He noted that Sri Lanka was largely self-sufficient in iodised table salt but was currently struggling to meet the demand for industrial salt essential for various applications

Sri Lanka needs 200,000 MT of salt annually, but the local salterns produce only 150,000 to 170,000 MT. A significant shortfall exists in vacuum salt production, a chemically purified type of salt used extensively in industries such as food preservation, confectionery, mineral solutions like Jeevani, animal feed, vitamin supplements, and water purification. While the demand for vacuum salt is around 30,000 to 40,000 MT annually, Sri Lanka produces only about 3,000 MT.

Hambantota and Puttalam are Sri Lanka’s primary salterns, with the former’s 1,000-acre facility capable of producing up to 100,000 MT annually and Puttalam’s 800-acre saltern offering a potential output of 60,000 MT. Smaller facilities include the saltern at Manthai, Mannar, which has a capacity of 8,000 MT but produces only 4,000 MT currently, and Elephant Pass, with a potential of 20,000 MT but producing 12,000 MT. A new saltern is also under construction in Kuchchaveli.

Sri Lankan salterns produce sea salt using solar evaporation, a natural process where seawater enters shallow ponds and evaporates, leaving salt crystals. As this method relies on environmental conditions, several factors must be considered when establishing new salterns.

Key considerations include soil characteristics, average wind speed, sunlight availability, and low rainfall levels. Seawater salinity is particularly critical; for instance, Hambantota’s high salinity levels make it highly productive for salt extraction. In contrast, the Northern and Eastern regions, as well as Puttalam, have comparatively lower seawater salinity, which impacts their potential salt yields. Identifying suitable locations requires careful evaluation of these factors to ensure optimal production.

In 2024, altered rainfall patterns driven by climate change brought significant rainfall to many areas where salterns are located. Dr. Rathnayake emphasised the need to improve the efficiency of existing salterns and minimise waste to adapt to such conditions, which may persist in the future. He also stressed the importance of establishing new salterns to meet the country’s entire salt demand.

“Kurinchantivu, near Elephant Pass, is a promising location,” he noted. “Historically, there was a saltern in the area, but operations ceased during the war. The site has the potential to host a 1,000-acre saltern, comparable in size to the one in Hambantota. Another opportunity lies in reviving the old saltern in Chemmani, which is currently non-operational, offering a chance to kickstart industries in the Northern region.”

Dr. Rathnayake explained that while the salinity of the seawater in Kurinchantivu is lower than in Hambantota, the location could still produce approximately 30,000 tonnes annually. He also recommended conducting studies to explore the feasibility of establishing salterns in the Eastern Province.

The senior lecturer at the Moratuwa University identified Panama and Palatupana, located near Hambantota, as areas with significant potential for salt production. He explained that the proximity to Hambantota ensures high salinity in the surrounding seas, where salt naturally forms.

He also highlighted the potential of salterns as eco-tourism attractions, noting the unique ecosystems they support. In other countries, salterns are popular tourist destinations due to the diverse wildlife adapted to high-salinity environments. “For example, flamingos thrive in these ecosystems,” he said.

Dr. Rathnayake pointed out that Sri Lanka’s salterns could also support the farming of Artemia salina, a species of brine shrimp. “These shrimp are highly valuable and widely used as animal feed, with a kilogram fetching approximately 15,000 rupees. Farming Artemia during off-seasons for salt production could be a lucrative venture. This would not only diversify income but also provide an opportunity to increase workers’ wages,” he explained.

He suggested further diversification by commercialising bittern, the bitter liquid left after sodium chloride crystallises. Bittern is used in Japan to produce tofu and can also be applied in industrial wastewater treatment. Other industries, such as manufacturing coconut fertilisers, caustic soda, and chlorine, could also be developed around salterns.

“By diversifying production and exploring these opportunities, salterns can become hubs for economic growth, bringing in more revenue and creating additional industries,” he said.

Continue Reading

Trending